Company Active LTD

Company profile

Astex Therapeutics Limited

UK company 03751674, incorporated on 14 April 1999.

Astex Oncology and CNS Drug Discovery & Development

Astex Therapeutics Limited is a UK company with status Active founded in 1999 based in East of England.

Company number

03751674

Incorporated

14 Apr 1999

Companies House status

Active

Company identity

Founded / incorporated

14 April 1999

Company number 03751674

Verify at Companies House

Legal name

ASTEX THERAPEUTICS LIMITED

Company type

Private Limited Company

Region

East of England

Registered address

436 CAMBRIDGE SCIENCE PARK

MILTON ROAD

CAMBRIDGE

CB4 0QA

Insolvency history

No

Corporate ownership

Updated 07 Jul 2026 09:49

10 levels 1 ultimate controller

1

Company Active LTD

Astex Therapeutics Limited

CRN 03751674

2

Direct controller Active LTD

Megabus.Com (UK) Limited

CRN 02199821

3

Intermediate controller Active LTD

Stagecoach Bus Holdings Limited

CRN SC176671

4

Intermediate controller Active LTD

Scusi Limited

CRN 03787587

5

Intermediate controller Active LTD

Scoto Limited

CRN 03795345

6

Intermediate controller Active LTD

Stagecoach Transport Holdings Limited

CRN SC183051

7

Intermediate controller Active PLC

Stagecoach Group Limited

CRN SC100764

8

Intermediate controller Active LTD

Inframobility UK Bidco Limited

CRN 13957417

9

Intermediate controller Active LTD

Inframobility UK Midco Limited

CRN 13954049

10

Intermediate controller Active LTD

Inframobility UK Holdco Limited

CRN 13949468

11

Ultimate controller Active LTD

Inframobility UK Topco Limited

CRN 13919225

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FULLACCOUNTS

Turnover

Unknown

Profit / Loss

£189,226,912

Employees

173

Company events

Reference milestones and recent Companies House filing stream events.

5 events

30 Sep

2027

Accounts due

Accounts Due

Next accounts due date

16 May

2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

02 May

2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec

2025

Accounts filed

Accounts

Last accounts made up date

14 Apr

1999

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards

First funded

2021

Funded years

2021, 2023

Age at first award

22 years

Projects

2023 Collaborative R&D

Genetic analysis for stratification and discovery in dementia patients by extending the NOMALY framework to non-coding variation

1 Sep 2023 to 31 Aug 2025

Awarded

£26,342

Total cost £52,684

OutSee Limited working with Astex Pharmaceuticals will be unlocking value and insights in non-coding genomic data through the _Nomaly_ approach to support precision medicine for dementia patients. We will be developing new AI to tackle the non-coding part of the genome alongside discovery developed on the protein-coding variation in the genome. Dementia i...

2021 Feasibility Studies

Practical improvements to the performance of quantum simulation for drug-protein binding

1 Nov 2021 to 30 Apr 2023

Awarded

£0

Total cost £23,897

The process of discovering and testing new drugs is very expensive and takes a long time. The average cost of discovering a new drug and bringing it to market has tripled since 2010, reaching almost $3bn in 2018\. Current methods for discovering new drugs are unreliable and involve a 'trial-and-error' approach. Pharmaceutical companies want to reduce the ...

Product types

Collaborative R&D Feasibility Studies